1Cardoso F,Van‘t Veer L,Rutgers E,et al.Clinical application of the70-gene profile:the MINDACTtrial[].Journal of Clinical Oncology.2008
2Liang H,Brufsky A M,Lembersky B B,et al.A retrospective analysis of the i mpact of oncotype DX low recurrence score results on treat ment decisions in a single academic breast cancer center[].Breast Cancer Research.2007
3Oratz R,,Paul D,Cohn A,et al.I mpact of oncotype DX on decision making in breast cancer clinical practice[].Breast Cancer Research.2006
4Lo S S,NortonJ,Mumby P B,et al.Prospective multicenter study of thei mpact of the21-gene recurrence score(RS)assay on medical oncologist(MO)and patient(pt)adjuvant breast cancer(BC)treat ment selection[].Proceedings of the American Society of Clinical Oncology.2007
5Lyman G H,Cosler L E,Kuderer N M,et al.I mpact of a21-gene RT-PCRassay ontreat ment decisions in early-stage breast cancer:an economic analysis based on prognostic and predictive validation studies[].Cancer.2007
6Hornberger J,Cosler LE,Lyman G H.Economic analysis of targetingchemotherapy usinga21-gene RT-PCRassay in lymph-node-negative,estrogen-receptor-positive,early-stage breast cancer[].AmJ Manag Care.2005
7Goldstein L J,Gray R,Badve S,et al.Prognostic utility of the21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features[].Journal of Clinical Oncology.2008
8Albain K,Barlow W,Shak S,et al.Prognostic and predictive value of the21-gene recurrence score assay in post menopausal,node-positive,ER-positive breast cancer(S8814,INT0100)[].Breast Cancer Research.2007
9Perou C M,Sorlie T,Eisen M B,et al.Molecular portraits of human breast tumours[].Nature.2000
10Sorlie,T,Tibshirani,R,Parker,J,Hastie,T,Marron,JS,Nobel,A,Deng,S,Johnsen,H,Pesich,R,Geisler,S,Demeter,J,Perou,CM,Lonning,PE,Brown,PO,Borresen-Dale,AL,Botstein,D.Repeated observation of breast tumor subtypes in independent gene expression data sets[].Proceedings of the National Academy of Sciences of the United States of America.2003
3Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma [ J ]. Clin Cancer Res, 2004, 10 ( 16 ) : 5367-5374.
4Rapiti E, Fioretta G, Verkooijen HM, et al. Survival of young and older breast cancer patients in Geneva from 1990 to 2001 [J]. Eur J Cancer, 2005, 41 (10) : 1446-1452.
5Perou CM, Scrlie T, Eisen MB, et al. Molecular portraits of human breast tumors [J]. Nature, 2000, 406(6797) : 747-752.
6lhemelandu CU, Leffall LD, Dewitty RL, et al. Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival [J]. J Surg Res, 2007, 143(1) : 109-118.
7Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study [ J ]. JAMA, 2006, 295(21 ): 2492-2502.
8Haffty BG, Yang Q, Reiss M, et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer[J]. J Clin Oncol, 2006, 24(36): 5652-5657.
